![]() Whilst it looks like middle and low-income countries are being pushed out by wealthier countries’ bids for vaccines, there may be a saving grace: the COVAX initiative. Ĭovid-19 Vaccine Doses… How many have been secured by various countries Source: Duke University Launch and Scale Speedometer Analysis by: InShorts /W7vv2ykta6 Making this point even starker, Canada has bought enough doses to vaccinate its entire population five times over whilst “ 90% of people in 67 low-income countries stand little chance of getting vaccinated against covid-19 in 2021,” according to the British Medical Journal. Total confirmed vaccine purchases are estimated at 7.2 billion doses, half of which are from the EU and five other rich countries despite only accounting for 13% of the world’s population. With limited initial vaccine supplies, wealthier countries are securing stockpiles of vaccines and preventing less affluent nations from receiving the bare minimum of what they need. Sinovac already has deals in place that will see 60 million doses delivered to Brazil and another 60 million to Chile, with Morocco also recently ordering 10 million doses of the Sinopharm vaccine. ![]() ” Delivering to this, China is stepping up to meet much of Latin America and Africa’s vaccine demands. Pioneering four of the world’s leading COVID-19 vaccines, China will play a pivotal role in world immunization.įollowing a notion of vaccine diplomacy, China’s President Xi Jinping declared that Chinese vaccines will be made a “ global public good. According to Zheng Zhongwei, head of China’s COVID-19 taskforce, the country has the capacity to produce 600 million doses this year and another billion in 2021. The latter has two vaccines with one already approved for emergency use in the city of Jiaxing similar to Sinovac’s emergency approval for health care workers in the U.A.E. #RDIF and one of India’s leading generic pharmaceutical companies have agreed to produce in #India over 100 million doses per year of the world’s first registered vaccine against the novel #coronavirus infection – /PPLOiChbR9įour leading contenders of COVID-19 vaccines are emerging from Chinese pharmaceutical companies CanSino Biologics Inc. This expanding production and distribution of Sputnik V may hold the potential to flood the global vaccine market in the near future. A further 100 million doses will be produced by a leading Indian pharmaceutical company Hetero as part of their recent agreement with the Russian Direct Investment Fund. ![]() These numbers will skyrocket as President Putin’s mass vaccination project takes effect and the production of 2 million doses nears completion. According to the Russian Health Minister Mikhail Murashko, 100,000 people have already been vaccinated whilst current Sputnik V trials involve a total of 40,000 people. Since then, Moscow has shipped the vaccine to various countries across Latin America and the Middle East as part of clinical trials. Propelling the notion of a race, Russia became the first country to approve a COVID-19 vaccine this summer, its own Sputnik V, even before it had passed all trial stages. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |